Cargando…
Application of E-coach chronic disease management model in rehabilitation management of patients with arteriosclerosis obliterans
OBJECTIVE: To explore the effect of a health (E)-coach chronic disease management model on the rehabilitation behaviour management of patients with arteriosclerosis obliterans (ASO). METHODS: The E-coach chronic disease management model was constructed based on a literature review and expert intervi...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612356/ https://www.ncbi.nlm.nih.gov/pubmed/37891631 http://dx.doi.org/10.1186/s41043-023-00454-7 |
_version_ | 1785128686445395968 |
---|---|
author | Yuan, You-Yuan Cao, Wen-Dong Zhang, Xiao-Hong Du, Rong-Xin Wang, Xue-Qi Li, Jing Chen, Juan Yang, Jun-Zi Chen, Jia-Qi |
author_facet | Yuan, You-Yuan Cao, Wen-Dong Zhang, Xiao-Hong Du, Rong-Xin Wang, Xue-Qi Li, Jing Chen, Juan Yang, Jun-Zi Chen, Jia-Qi |
author_sort | Yuan, You-Yuan |
collection | PubMed |
description | OBJECTIVE: To explore the effect of a health (E)-coach chronic disease management model on the rehabilitation behaviour management of patients with arteriosclerosis obliterans (ASO). METHODS: The E-coach chronic disease management model was constructed based on a literature review and expert interviews. The effect of the E-coach model on patients with ASO during hospitalisation was analysed by comparing the compliance rates of blood glucose control, blood pressure control, drug compliance, ankle-brachial index, 6-min walking test (6MWT) and pain-free walking distance (PFWD) scores between the E-coach and control groups. RESULTS: In total, 212 patients with ASO were included in this study. After the intervention, the blood pressure compliance rate (44.8% vs. 65.7%) and blood glucose compliance rate (48.6% vs. 66.8%) were higher in the E-coach group than in the control group (p < 0.05). After intervention, compared with the control group, the patients in the E-coach group had better drug compliance (6.8 ± 1.9 vs. 7.9 ± 1.0), and the difference was statistically significant (p < 0.05). The scores for the 6MWT (329.19 ± 5.58 vs. 353.00 ± 9.76; 412.65 ± 12.59 vs. 499.16 ± 18.43) and PFWD (219.15 ± 11.96 vs. 225.36 ± 16.13; 331.62 ± 51.36 vs. 369.42 ± 75.71) tests were significantly higher in the E-coach group than in the control group at 1 and 6 months after intervention (p < 0.05). CONCLUSION: The E-coach chronic disease management model can effectively improve the control rates of blood glucose and blood pressure and the behaviour management of patients with ASO and is thus worthy of clinical reference. |
format | Online Article Text |
id | pubmed-10612356 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-106123562023-10-29 Application of E-coach chronic disease management model in rehabilitation management of patients with arteriosclerosis obliterans Yuan, You-Yuan Cao, Wen-Dong Zhang, Xiao-Hong Du, Rong-Xin Wang, Xue-Qi Li, Jing Chen, Juan Yang, Jun-Zi Chen, Jia-Qi J Health Popul Nutr Research OBJECTIVE: To explore the effect of a health (E)-coach chronic disease management model on the rehabilitation behaviour management of patients with arteriosclerosis obliterans (ASO). METHODS: The E-coach chronic disease management model was constructed based on a literature review and expert interviews. The effect of the E-coach model on patients with ASO during hospitalisation was analysed by comparing the compliance rates of blood glucose control, blood pressure control, drug compliance, ankle-brachial index, 6-min walking test (6MWT) and pain-free walking distance (PFWD) scores between the E-coach and control groups. RESULTS: In total, 212 patients with ASO were included in this study. After the intervention, the blood pressure compliance rate (44.8% vs. 65.7%) and blood glucose compliance rate (48.6% vs. 66.8%) were higher in the E-coach group than in the control group (p < 0.05). After intervention, compared with the control group, the patients in the E-coach group had better drug compliance (6.8 ± 1.9 vs. 7.9 ± 1.0), and the difference was statistically significant (p < 0.05). The scores for the 6MWT (329.19 ± 5.58 vs. 353.00 ± 9.76; 412.65 ± 12.59 vs. 499.16 ± 18.43) and PFWD (219.15 ± 11.96 vs. 225.36 ± 16.13; 331.62 ± 51.36 vs. 369.42 ± 75.71) tests were significantly higher in the E-coach group than in the control group at 1 and 6 months after intervention (p < 0.05). CONCLUSION: The E-coach chronic disease management model can effectively improve the control rates of blood glucose and blood pressure and the behaviour management of patients with ASO and is thus worthy of clinical reference. BioMed Central 2023-10-27 /pmc/articles/PMC10612356/ /pubmed/37891631 http://dx.doi.org/10.1186/s41043-023-00454-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Yuan, You-Yuan Cao, Wen-Dong Zhang, Xiao-Hong Du, Rong-Xin Wang, Xue-Qi Li, Jing Chen, Juan Yang, Jun-Zi Chen, Jia-Qi Application of E-coach chronic disease management model in rehabilitation management of patients with arteriosclerosis obliterans |
title | Application of E-coach chronic disease management model in rehabilitation management of patients with arteriosclerosis obliterans |
title_full | Application of E-coach chronic disease management model in rehabilitation management of patients with arteriosclerosis obliterans |
title_fullStr | Application of E-coach chronic disease management model in rehabilitation management of patients with arteriosclerosis obliterans |
title_full_unstemmed | Application of E-coach chronic disease management model in rehabilitation management of patients with arteriosclerosis obliterans |
title_short | Application of E-coach chronic disease management model in rehabilitation management of patients with arteriosclerosis obliterans |
title_sort | application of e-coach chronic disease management model in rehabilitation management of patients with arteriosclerosis obliterans |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612356/ https://www.ncbi.nlm.nih.gov/pubmed/37891631 http://dx.doi.org/10.1186/s41043-023-00454-7 |
work_keys_str_mv | AT yuanyouyuan applicationofecoachchronicdiseasemanagementmodelinrehabilitationmanagementofpatientswitharteriosclerosisobliterans AT caowendong applicationofecoachchronicdiseasemanagementmodelinrehabilitationmanagementofpatientswitharteriosclerosisobliterans AT zhangxiaohong applicationofecoachchronicdiseasemanagementmodelinrehabilitationmanagementofpatientswitharteriosclerosisobliterans AT durongxin applicationofecoachchronicdiseasemanagementmodelinrehabilitationmanagementofpatientswitharteriosclerosisobliterans AT wangxueqi applicationofecoachchronicdiseasemanagementmodelinrehabilitationmanagementofpatientswitharteriosclerosisobliterans AT lijing applicationofecoachchronicdiseasemanagementmodelinrehabilitationmanagementofpatientswitharteriosclerosisobliterans AT chenjuan applicationofecoachchronicdiseasemanagementmodelinrehabilitationmanagementofpatientswitharteriosclerosisobliterans AT yangjunzi applicationofecoachchronicdiseasemanagementmodelinrehabilitationmanagementofpatientswitharteriosclerosisobliterans AT chenjiaqi applicationofecoachchronicdiseasemanagementmodelinrehabilitationmanagementofpatientswitharteriosclerosisobliterans |